Learn Now with this Article on Pharmacology by Katrina L. Mealey
Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association | Circulation
IJMS | Free Full-Text | Novel Heat Shock Protein 90 Inhibitors Suppress P- Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells
Mechanisms of classical P-gp inhibitors. | Download Table
P-glycoprotein - Wikipedia
Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells | Scientific Reports
Clinically Significant Drug Interactions - ppt video online download
Frontiers | Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics
P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review - ScienceDirect
Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability - Pharma Excipients
List of the known P-gp substrates and inhibitors. | Download Scientific Diagram
Selected substrates and modulators of P-glycoprotein | Download Table
Apixaban (Eliquis®) – Drug-Drug-Interaction Considerations in COVID-19 Patients with Coagulation Abnormalities - Anesthesia Patient Safety Foundation
Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms - ScienceDirect
The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions - Document - Gale OneFile: Health and Medicine
P-glycoprotein
SciELO - Brasil - Overview of P-glycoprotein inhibitors: a rational outlook Overview of P-glycoprotein inhibitors: a rational outlook
Table 1 from Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Semantic Scholar
Table 2 from Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | Semantic Scholar
